| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.05 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |